Bory M, Joly P, Bonnet J L, Djiane P, Serradimigni A
Department of Cardiology, Centre Hospitalier Universitaire Timone, Marseille, France.
Am J Cardiol. 1988 Feb 1;61(4):298-302. doi: 10.1016/0002-9149(88)90934-4.
To evaluate the incidence of spasm in patients with angiographically normal coronary arteries or with stenosis less than or equal to 50%, methergin testing was done consecutively in 1,200 patients (742 men and 458 women). The methergin test was performed 850 times during coronary angiography and 350 times after it. The test was globally positive in 11% (127 of 1,200 patients), positive in 7% among 921 patients presenting with atypical chest pain, 13% of 31 patients with effort angina, 54% of 54 with angina at rest, 57% of 53 with Prinzmetal's angina, 3% of 59 with acute myocardial infarction and 1% of 82 miscellaneous patients without chest pain. Another test was done in 291 patients after blockade of the cardiac autonomous nervous system with 0.04 mg/kg of atropine and 2 mg/kg of labetolol. The frequency of positive results in the methergin test increased after blockade from 8 to 19% (p less than 0.01). The increase of positive results was especially obvious among patients with atypical chest pain (from 6 to 14%). Thus, frequency of spasm in these patients with normal coronary arteries or without significative lesions was 11%. This incidence was influenced by the composition of the patient population and increased with blockade of the cardiac autonomous nervous system.
为评估冠状动脉造影正常或狭窄程度小于或等于50%的患者中痉挛的发生率,对1200例患者(742例男性和458例女性)连续进行了麦角新碱试验。麦角新碱试验在冠状动脉造影期间进行了850次,造影后进行了350次。该试验总体阳性率为11%(1200例患者中的127例),在921例表现为非典型胸痛的患者中阳性率为7%,31例劳力性心绞痛患者中为13%,54例静息性心绞痛患者中为54%,53例变异型心绞痛患者中为57%,59例急性心肌梗死患者中为3%,82例无胸痛的其他患者中为1%。对291例患者在使用0.04mg/kg阿托品和2mg/kg拉贝洛尔阻断心脏自主神经系统后进行了另一项试验。麦角新碱试验阳性结果的频率在阻断后从8%增加到19%(p<0.01)。阳性结果的增加在非典型胸痛患者中尤为明显(从6%增加到14%)。因此,这些冠状动脉正常或无明显病变的患者中痉挛的发生率为11%。这一发生率受患者群体构成的影响,并随着心脏自主神经系统的阻断而增加。